NEW YORK ( TheStreet) -- Cephalon Inc (Nasdaq: CEPH) hit a new 52-week high Thursday as it is currently trading at $81.15, above its previous 52-week high of $81.14 with two million shares traded as of 1:50 p.m. ET. Average volume has been 3.9 million shares over the past 30 days. Cephalon has a market cap of $6.3 billion and is part of the health care sector and drugs industry. Shares are up 31.1% year to date as of the close of trading on Wednesday. Cephalon, Inc., a biopharmaceutical company, engages in discovering and developing medicines for central nervous system disorders, pain, oncology, inflammatory disease, and regeneration worldwide. The company has a P/E ratio of 15.9, above the average drugs industry P/E ratio of 11.9 and below the S&P 500 P/E ratio of 17.7.
- Practice your CEPH trading strategies and win cash in our stock game.